Feature

Evergen pushing the boundaries of tissue engineering in regenerative medicine

Closely-held Evergen, formerly RTI Surgical, is advancing innovative medical solutions across the cardiac, sports and orthopedics, plastic and reconstructive surgery, and neuro-spine clinical segments as the only...

March 4, 2025

Feature

Climb driving transformational therapies in immune-mediated diseases

Climb Bio (NASDAQ:CLYM) is advancing a pipeline of best-in-class, patient-tailored therapeutics to address the unmet needs of complex and clinically-diverse immune-mediated diseases.

February 18, 2025

Feature

MOBILion trailblazing next-gen separation science to reveal what others leave unseen

Closely-held MOBILion Systems is redefining analytical characterization through its next-generation separation science platform that is integrated with high-resolution mass spectrometry to achieve unprecedented...

February 4, 2025

Feature

VICO addressing severe neurological diseases at the source with RNA modulating therapies

Closely-held VICO Therapeutics is developing antisense oligonucleotide (ASO) RNA modulating therapies for patients with severe genetic neurological diseases, including Huntington’s disease (HD) and spinocerebellar...

January 21, 2025